000 | 00914 a2200265 4500 | ||
---|---|---|---|
005 | 20250513151253.0 | ||
264 | 0 | _c19981203 | |
008 | 199812s 0 0 eng d | ||
022 | _a0195-668X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVaughan, D E | |
245 | 0 | 0 |
_aFibrinolytic balance, the renin-angiotensin system and atherosclerotic disease. _h[electronic resource] |
260 |
_bEuropean heart journal _cJul 1998 |
||
300 |
_aG9-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArteriosclerosis _xdrug therapy |
650 | 0 | 4 |
_aFibrinolysis _xdrug effects |
650 | 0 | 4 |
_aHomeostasis _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
650 | 0 | 4 | _aRisk Factors |
773 | 0 |
_tEuropean heart journal _gvol. 19 Suppl G _gp. G9-12 |
|
999 |
_c9682495 _d9682495 |